Catalyst
Slingshot members are tracking this event:
RDUS Phase 2b Data for Elacestrant (RAD1901) for Postmenopausal Vasomotor Symptoms Expected Second Half 2017 - Discontinued
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RDUS |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 07, 2017
Occurred Source:
http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=1051165
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Elacestrant, Rad1901, Postmenopausal
